Effect of Aerobic Training on Sleep Problems and Pulmonary Functions in Children With Down Syndrome

Sponsor
Cairo University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05861141
Collaborator
(none)
30
2
12

Study Details

Study Description

Brief Summary

The study will be conducted to determine the effect of aerobic training on sleep problems and pulmonary functions in children with Down syndrome.

Condition or Disease Intervention/Treatment Phase
  • Other: Selected physical therapy program
  • Device: Aerobic training
N/A

Detailed Description

The study will be carried out on 30 children with Down syndrome (trisomy 21) of both sexes, with ages ranging from 7 to 12 years old. Children will be recruited from schools for special needs. Children will be randomly assigned into two equal groups (control and study groups), 15 for each group. The control group will receive a selected physical therapy program only, while the study group will receive the same selected physical therapy program as the control group in addition to aerobic exercise in the form of treadmill training. The Arabic version of the Children's Sleep Habits Questionnaire (CSHQ) will be used to assess sleep problems, while a handheld spirometer will be used to assess pulmonary functions (forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, and peak expiratory flow rate (PEFR)) pre- and post-intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effect of Aerobic Training on Sleep Problems and Pulmonary Functions in Children With Down Syndrome
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Group

Patients will receive a selected physical therapy program only.

Other: Selected physical therapy program
Patients will receive a selected physical therapy program for 1 hr, 3 times per week, for 3 successive months in the form of: Balance and postural control exercises for 15 minutes, including the following: Standing on balance board. Stoop and recovery. Gait training for 45 minutes, including the following: Forward, backward, and sideways walking. Walking with obstacles using wedges and rolls with different diameters and heights.

Experimental: Study Group

Patients will receive the same selected physical therapy program as the control group in addition to aerobic exercise in the form of treadmill training.

Device: Aerobic training
Patients will receive the same selected physical therapy program as the control group for 15 minutes in addition to treadmill training for 45 minutes, 3 times per week, for 3 successive months. Treadmill training: Will be practiced according to the following stages: A- Warm up: 5 minutes. B- The exercise phase: 35 minutes (three-minute stages), the speed will be increased gradually every 3 minutes intervals until the child no longer be able to walk at the current stage. C- Cool down: 5 minutes.
Other Names:
  • Treadmill training
  • Outcome Measures

    Primary Outcome Measures

    1. Sleep Problems: [6 months]

      Will be measured by the Arabic version of the Children's Sleep Habits Questionnaire (CSHQ): A 33-item retrospective parent-report questionnaire was created as a screening tool for sleep issues over a "typical" recent week. Each item is scored 1-3 (1 = Rarely, 0-1x/week; 2 = Sometimes, 2-4x/week; 3 = Usually, 5-7x/week). There are 6 questions with reverse scoring in order to consistently make a higher score indicative of more disrupted sleep. This will yield a total score between 33 and 99. A total score of 41 or higher suggests the presence of a sleep disturbance.

    Secondary Outcome Measures

    1. Forced Vital Capacity (FVC): [6 months]

      Pulmonary Functions: FVC will be measured by a handheld spirometer.

    2. Forced Expiratory Volume in 1 second (FEV1): [6 months]

      Pulmonary Functions: FEV1 will be measured by a handheld spirometer.

    3. FEV1/FVC ratio: [6 months]

      Pulmonary Functions: FEV1/FVC ratio will be measured by a handheld spirometer.

    4. Peak Expiratory Flow Rate (PEFR): [6 months]

      Pulmonary Functions: PEFR will be measured by a handheld spirometer.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Children with Down syndrome (trisomy 21).

    • Their ages range from 7 to 12 years old.

    • Both sexes will be included.

    • Children should be able to understand and follow simple verbal commands or instructions (intelligence quotient (IQ) range: 50-70).

    • Children should be able to walk independently.

    • Their total scores on the Arabic version of the Children's Sleep Habits Questionnaire (CSHQ) equal 41 or higher.

    Exclusion Criteria:
    Children will be excluded from the study if they:
    • Have visual or hearing defects.

    • Have spinal abnormality such as kyphosis and scoliosis.

    • Have history of pulmonary infection and surgery of thoracic and abdominal region within the past 6 months.

    • Play any specific sport or exercises.

    • Have physical activity restrictions.

    • Have musculoskeletal disorder.

    • Take medications known to affect sleep.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Cairo University

    Investigators

    • Principal Investigator: Naglaa A Zaky, PhD, Professor of Physical Therapy for Pediatrics, Faculty of Physical Therapy, Cairo University
    • Principal Investigator: Saly S Abd Elhady, PhD, Lecturer of Physical Therapy for Pediatrics, Faculty of Physical Therapy, Cairo University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mayar Abdel Mohsen Ahmed Magd Behairy, Physiotherapy Practitioner, Cairo University
    ClinicalTrials.gov Identifier:
    NCT05861141
    Other Study ID Numbers:
    • P.T.REC/012/004243
    First Posted:
    May 16, 2023
    Last Update Posted:
    May 16, 2023
    Last Verified:
    May 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mayar Abdel Mohsen Ahmed Magd Behairy, Physiotherapy Practitioner, Cairo University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 16, 2023